Inflammatory Cancers
Image Analysis is closely working with a number of research and clinical organisations interested in gaining better understanding of detection, staging and ultimately diagnosis of cancer through imaging biomarkers.
IA’s proprietary software platform, Dynamika, has been designed with input from our customers and key opinion leaders in the field of oncology. Dynamika incorporates the latest scientific thinking implemented in fully and semi-automated algorithms for
- Patient Motion Reduction
- Objective Quantification of Inflammatory Activity
- Measurements of imaging biomarkers such as Maximum Enhancement (ME), Initial Rate of Enhancement (IRE), Time of Onset of Enhancement, and Rate of Wash-Out
- Voxel–by–voxel Analysis
- Computer Guided Region of Interest based Analysis
- Pharmacokinetic Measurements of k-trans
The algorithms used for quantification of disease activity and tissue delineation are independent of the imaged anatomy, MRI equipment manufacture, the strength of the scanner or intensity based threshold value. Thus,
- Allowing analysing and comparing retrospective and prospective MRI studies for same and different patients
- Extracting imaging biomarkers reflecting disease activity in short and long terms follow-ups
- Understanding impact of chemotherapy
- Fully automatically and therefore objectively measure treatment effect
- Correlate imaging biomarkers and histology data
Our customers work with images acquired from patients with breast cancer, prostate cancer, inflammatory bowel disease, and bone sarcomas.
We always welcome new suggestions from the customers, which will be used to guide our
future development and delivery of the best possible solutions for medical data analysis